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Nitric oxide stress and activation of AMP-activated
protein kinase impair β-cell sarcoendoplasmic reticulum
calcium ATPase 2b activity and protein stability
X Tong1, T Kono2 and C Evans-Molina*,1,2,3,4,5
The sarcoendoplasmic reticulum Ca2+ ATPase 2b (SERCA2b) pump maintains a steep Ca2+ concentration gradient between the
cytosol and ER lumen in the pancreatic β-cell, and the integrity of this gradient has a central role in regulated insulin production
and secretion, maintenance of ER function and β-cell survival. We have previously demonstrated loss of β-cell SERCA2b
expression under diabetic conditions. To define the mechanisms underlying this, INS-1 cells and rat islets were treated with the
proinflammatory cytokine interleukin-1β (IL-1β) combined with or without cycloheximide or actinomycin D. IL-1β treatment led to
increased inducible nitric oxide synthase (iNOS) gene and protein expression, which occurred concurrently with the activation of
AMP-activated protein kinase (AMPK). IL-1β led to decreased SERCA2b mRNA and protein expression, whereas time-course
experiments revealed a reduction in protein half-life with no change in mRNA stability. Moreover, SERCA2b protein but not mRNA
levels were rescued by treatment with the NOS inhibitor L-NMMA (NG-monomethyl L-arginine), whereas the NO donor SNAP
(S-nitroso-N-acetyl-D,L-penicillamine) and the AMPK activator AICAR (5-aminoimidazole-4-carboxamide ribonucleotide) recapitu-
lated the effects of IL-1β on SERCA2b protein stability. Similarly, IL-1β-induced reductions in SERCA2b expression were rescued
by pharmacological inhibition of AMPK with compound C or by transduction of a dominant-negative form of AMPK, whereas β-cell
death was prevented in parallel. Finally, to determine a functional relationship between NO and AMPK signaling and SERCA2b
activity, fura-2/AM (fura-2-acetoxymethylester) Ca2+ imaging experiments were performed in INS-1 cells. Consistent with observed
changes in SERCA2b expression, IL-1β, SNAP and AICAR increased cytosolic Ca2+ and decreased ER Ca2+ levels, suggesting
congruent modulation of SERCA activity under these conditions. In aggregate, these results show that SERCA2b protein stability
is decreased under inflammatory conditions through NO- and AMPK-dependent pathways and provide novel insight into pathways
leading to altered β-cell calcium homeostasis and reduced β-cell survival in diabetes.
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The pancreatic β-cell requires the maintenance of a robust
intraluminal endoplasmic reticulum Ca2+ pool to support high
levels of protein translation and proinsulin processing.
Calcium release from ER stores is also responsible for the
activation or augmentation of a number of key β-cell signaling
pathways, including glucose and incretin-induced insulin
secretion.1Although release of ER Ca2+ occurs through the
inositol 1,4,5-trisphosphate and ryanodine receptors (RyRs),
intraluminal ER Ca2+ levels are largely maintained through
activity of the sarcoendoplasmic reticulum calcium ATPase
(SERCA) pumps that transport twoCa2+ ions into the ER at the
expense of one ATP.2,3 In mammals, three different SERCA
genes (ATP2A1, ATP2A2 and ATP2A3) encode the proteins
SERCA1, 2 and 3, and to date, at least 14 isoforms have been
identified.4 SERCA2b is the most prevalent isoform expressed
in the mouse pancreatic islet,5 and we and others have
demonstrated diminished β-cell SERCA2b expression in
human and rodent models of type 1 and type 2 diabetes,
resulting in Ca2+ dyshomeostasis, impaired insulin secretion,
activation of ER stress signaling pathways and impaired β-cell
survival.5–9
Loss of β-cell SERCA2b expression under proinflammatory
and diabetic conditions is thought to occur, at least partially,
through nitric oxide (NO)-dependent mechanisms.6 However,
whether NO-mediated loss of SERCA2b expression and
activity is primarily due to transcriptional or posttranslational
mechanisms is not clear. Moreover, the downstream pathways
that synergize with NO signaling to alter endoplasmic
reticulum Ca2+ have not been fully defined. In this regard,
the activity and fidelity of ATPases including SERCA are highly
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dependent on overall cellular energy status. SERCA pumps
are estimated to consume 7–25% of total cellular ATP,
whereas ADP levels are closely correlated with SERCA
activity.10–12 A well-recognized downstream effect of proin-
flammatory cytokine signaling and NO production is an
impairment of mitochondrial function, leading to altered ATP
synthesis.13 Although these effects contribute to β-cell
dysfunction and apoptosis, they also lead to the activation of
AMP-activated protein kinase (AMPK), which serves as the
master sensor of cellular energy status.14 AMPK has a wide
number of downstream substrates involved in a variety of
processes including metabolism, inflammation and ion
transport.15 Interestingly, AMPK has been shown to regulate
directly the activity, expression and cellular localization of
other high-energy-consuming protein pumps including the
plasma membrane Na+,K+-ATPase in lung epithelial cells and
the H+ATPase of the intercalated cells of the kidney.16–18 This
level of interaction represents one mechanism through which
AMPK signaling may act to limit energy expenditure under
stress conditions. Interestingly, a recent proteomics study
performed in β-cells suggested a direct physical interaction
between AMPK and SERCA2,19 but a functional relationship
between these proteins in the β-cell remains unexplored.
Here, we first aimed to define the mechanisms through
which NO signaling impacts SERCA2b expression in the
pancreatic β-cell. Our second goal was to identify the
pathways that synergize with NO to regulate β-cell ER Ca2+
homeostasis under inflammatory conditions, hypothesizing a
novel role for chronic AMPK activation in the regulation of
SERCA2b activity.
Results
The proinflammatory cytokine IL-1β decreases SERCA2b
protein but not mRNA stability in both INS-1 cells and
isolated rat islets. Previous work by our group and others
have demonstrated significant downregulation of SERCA2b
mRNA and protein levels under diabetic conditions.5–8 To
determine whether this was secondary to alterations in either
mRNA or protein stability, actinomycin and cycloheximide
(CHX) time-course experiments were performed under basal
conditions and then following treatment with the proinflam-
matory cytokine interleukin-1β (IL-1β). Under control condi-
tions, β-cell SERCA2b mRNA exhibited a half-life of ~ 9 h,
and IL-1β treatment had no effect mRNA stability (Figure 1a).
In contrast, SERCA2 protein in INS-1 cells exhibited a half-life
of ~ 24 h under basal conditions (Figures 1b and c), and IL-1β
significantly reduced the half-life to ~ 19 h (Figures 1b and c).
In rat islets, the protein half-life was noted to be ~ 17 h under
control conditions, whereas treatment with IL-1β significantly
reduced the half-life to ~ 11 h (Figures 1d and e).
NO-dependent downregulation of SERCA2 occurs at the
translational level. Altered SERCA2b expression under
proinflammatory conditions is thought to occur at least partly
through NO-mediated signaling pathways.6 However, the
precise mechanisms underlying NO-mediated alterations in
SERCA2b expression have not been fully defined. To this end,
INS-1 cells were treated with IL-1β, combined with or without
the NO synthase (NOS) inhibitor, L-NMMA (NG-monomethyl
L-arginine), for 24 h.9 Following IL-1β treatment, loss of both
SERCA2b protein and mRNA expression was observed
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Figure 1 IL-1β treatment decreases SERCA2b protein stability in INS-1 cells and isolated rat islets. INS-1 cells (a–c) or isolated rat islets (d–e) were treated with 1 μM
actinomycin or 10 μM CHX combined with or without 5 ng/ml of IL-1β for indicated times. Total RNA and protein were isolated, and RNA was subjected to quantitative real-time
PCR (qRT-PCR) for quantification of SERCA2b and actin transcript levels. Immunoblot was performed using antibodies against SERCA2 and actin. Protein and mRNA levels were
plotted relative to levels at time zero, and one-phase decay lines for each treatment are shown. Indicated comparisons are significantly different (*Po0.05 and ***Po0.001)
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(Figures 2a–c). L-NMMA treatment was able to rescue
SERCA2b protein levels (Figures 2a and b). However, no
effect was observed on mRNA expression (Figure 2c). These
results were confirmed in rat islets (Figures 2d and e), where L-
NMMA also resulted in a partial rescue of SERCA2 expression
following treatment with the proinflammatory cytokine IL-1β.
INS-1 cells were treated next with IL-1β, combined with or
without the specific NO scavenger C-PTIO (carboxylated
derivative of 2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-
3-oxide; Figures 2f–h).10 Similar to effects observed with
L-NMMA, C-PTIO rescued SERCA2 protein but not transcript
levels, suggesting IL-1β-mediated effects on protein expres-
sion were indeed NO-dependent. To define whether NO was
then sufficient to exert this effect, INS-1 cells were treated with
the NO donor, SNAP (S-nitroso-N-acetyl-D,L-penicillamine).
As expected, SNAP decreased SERCA2 protein to a level
almost equivalent to that observed with IL-1β, whereas mRNA
levels were not significantly altered (Figures 2i–k). Nitrite
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Figure 2 NO-dependent loss of SERCA2 expression occurs at a translational level. INS-1 cells (a–c and f–h) or isolated rat islets (d–e) were treated with dimethyl sulfoxide
(DMSO) (CT) or IL-1β (IL) combined with or without 0.5 mM of the NOS inhibitor L-NMMA (LN) or 100 μM of the NO scavenger C-PTIO (CPT) for 24 h. Total protein was isolated
and immunoblot was performed using antibodies against SERCA2, iNOS and actin. Quantitative protein levels of SERCA2 are shown graphically (b, e and g). Total mRNA was
isolated from the INS-1 cells treated with CT, LN, IL, IL-LN or IL-CPT, and reverse-transcribed RNA was subjected to quantitative real-time PCR (qRT-PCR) for quantification of
SERCA2b and actin transcript levels (c and h). Next, INS-1 cells, isolated rat islets or human islets were treated with or without the NO donor SNAP (SN) at 300 mM for 24 h
(i–k and m–p). Total protein and mRNA were isolated. Immunoblot was performed using antibodies against SERCA2 and actin, and quantitative protein levels are shown
graphically (j, n and p). Reverse-transcribed RNA was subjected to qRT-PCR for quantification of SERCA2b and actin transcript levels (k). INS-1 culture media was collected at
treatment end, and nitrite concentration was measured (l). Results are statistically different from control conditions (j, l, n and p), or indicated comparisons are significantly
different (**Po0.01 and ***Po0.001)
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levels in the culture media were measured under each
experimental condition and found to increase with IL-1β and
SNAP treatment, whereas L-NMMA exhibited the expected
effect of decreased nitrite production following IL-1β treatment
(Figure 2l). Finally, to confirm these results in primary cells, rat
and cadaveric human islets were treated with SNAP.
Consistent with results observed in INS-1 cells, SERCA2
protein expression was significantly decreased compared with
control conditions in both rat and human islets (Figures 2m–p).
Activation of AMPKα Th173 contributes to SERCA2
downregulation at the translational level. The primary
goal of our study was to next define novel downstream
pathways that synergized with NO to influence SERCA2b
expression and the overall regulation of ER Ca2+ home-
ostasis. To test whether IL-1β-induced SERCA2 downregula-
tion could be linked to an AMPK-mediated effect, INS-1 cells
and isolated rat islets were treated with IL-1β combined with
or without the AMPK inhibitor, compound C (CC). Increased
levels of phosphorylated AMPKα Th173 were observed
following treatment with IL-1β, confirming previous findings
that proinflammatory cytokines lead to the activation of
AMPK signaling.14 Similarly, AMPK activation was blocked
by CC (Figure 3a). Interestingly, CC was also capable
of fully reversing IL-1β-mediated loss of SERCA2 protein
(Figures 3a and b). Again, these effects appeared to be
primarily restricted to protein expression as no significant
change in transcript levels were observed (Figure 3c). To
confirm this relationship, rat islets were treated with IL-1β and
CC. Similar to results obtained in INS-1 cells, altered SERCA2
protein expression under inflammatory conditions was pre-
vented by CC (Figures 3d and e). Next, to study whether direct
activation of AMPK was sufficient to decrease SERCA2
expression, INS-1 cells were treated with the AMPK agonist
AICAR (5-aminoimidazole-4-carboxamide ribonucleotide) for
24 h. Results demonstrated that AICAR indeed decreased
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Figure 3 Activation of AMPKα Th173 leads to a loss of SERCA2 protein expression. INS-1 cells (a–c) or isolated rat islets (d–e) were treated with dimethyl sulfoxide (DMSO)
(CT) or 5 ng/ml IL-1β (IL) combined with or without 10 μM of the AMPK inhibitor CC for 24 h. Total protein was isolated, and immunoblot was performed using antibodies against
SERCA2, phosphorylated AMPKα Th173 (pAMPKα), total AMPK and actin. Quantitative SERCA2 protein levels are shown graphically (b and e). Total mRNA was isolated from
INS-1 cells treated with CT, IL and IL-CC, and reverse-transcribed RNAwas subjected to quantitative real-time PCR (qRT-PCR) for quantification of SERCA2b and actin transcript
levels (c). Next, INS-1 cells or isolated rat islets and human islets were treated with and without the AMPK activator AICAR (AC) at 2 mM for 24 h (f–l). Total protein and mRNA
were isolated; immunoblot was performed using antibodies against SERCA2, pAMPKα, AMPK and actin. Quantitative protein levels of SERCA2 are shown graphically (g, j and l).
Reverse-transcribed RNA was subjected to qRT-PCR for quantification of SERCA2b and actin transcript levels (h). Indicated comparisons are significantly different (*Po0.05,
**Po0.01 and ***Po0.001), or results are statistically different from control conditions (g, j and l)
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SERCA2 protein expression to a level similar to that observed
with IL-1β and SNAP treatment (Figures 3f and g). Consistent
with previous results observed with SNAP, mRNA levels were
again unaffected (Figure 3h). Decreased SERCA2 protein
expression with AICAR-mediated AMPK activation was
confirmed in isolated rat islets and cadaveric human islets
(Figures 3i–l). In aggregate, these results indicate that
β-cell SERCA2 protein half-life is significantly altered under
inflammatory conditions and loss of protein expression
occurs concomitantly through NO and AMPK-dependent
mechanisms.
NO and activation of AMPK decrease SERCA2 protein
stability. To address next whether NO- and AMPK-mediated
loss of SERCA2 expression specifically resulted from
alterations in protein stability, INS-1 cells were treated with
CHX combined with or without SNAP or AICAR. Results
showed that treatment with both SNAP and AICAR signifi-
cantly reduced SERCA2 protein half-life (Figures 4a–c).
AMPK activation is required for IL-1β-induced down-
regulation of SERCA2 protein. INS-1 cells, rat islets and
human islets were next transduced with an HA-tagged
AMPK-DN or luciferase expressing control adenovirus to
further test the relationship between AMPK signaling and
SERCA2 expression. Reduced AMPK signaling with the
AMPK-DN construct was confirmed by reduction in the level
of phosphorylated acetyl-CoA carboxylase, a key down-
stream target of AMPK (Figures 5a, c and d).15 Virally
transduced INS-1 cells and rat islets were treated with IL-1β,
whereas human islets were treated with a combination of
IL-1β, IFN-γ and TNF-α (tumor necrosis factor-α). Interest-
ingly, the AMPK-DN adenovirus increased basal expression
of SERCA2 in rat and human islets (Figures 5c and d).
Moreover, in AMPK-DN-transduced INS-1 cells (Figures 5a
and b), rat islets (Figure 5c) and human islets (Figure 5d),
cytokine-induced reductions in SERCA2 protein expression
were prevented. Taken together, these data demonstrate that
AMPK is necessary for proinflammatory-induced down-
regulation of SERCA2 protein expression.
AMPK activation modulates IL-1β-induced iNOS expres-
sion and it is required in SNAP-induced downregulation
of SERCA2. To study further the relationship between
AMPK and NO signaling following cytokine stress, INS-1 cell
and rat islets were treated with CC concurrently with IL-1β.
Interestingly, inducible nitric oxide synthase (iNOS) protein
expression was significantly decreased in the presence of CC
(Figures 6a–c). Similarly, decreased iNOS gene expression
was observed in INS-1 cells treated with CC and IL-1β
(Figure 6h). To rule out nonspecific effects from the use of
pharmacological inhibitors, INS-1 cells and rat islets
were again transduced with the AMPK-DN or control
adenovirus and subsequently treated with IL-1β. In AMPK-
DN-transduced INS-1 cells and rat islets, a similar reduction
in iNOS expression was noted following IL-1β treatment, and
reduced iNOS gene expression was observed (Figures
6d–f, i). This relationship was confirmed by measuring nitrite
production, where results showed that IL-1β-mediated
increases in nitrite production were markedly reduced with
CC and partially reduced in INS-1 cells transduced with the
AMPK-DN adenovirus (Figure 6g). To define whether AMPK
activation was then necessary for SNAP-induced loss of
SERCA2 expression, INS-1 cells were treated with SNAP
combined with or without CC. Interestingly, SERCA2 protein
expression was indeed preserved by CC treatment (Figures
6j and k).
In aggregate, our data showed that AMPK is activated under
inflammatory conditions and IL-1β-mediated reductions in
SERCA2 expression were partially AMPK-dependent. How-
ever, our results also showed that AMPK signaling led to an
amplification of NO-mediated inflammatory responses in the
pancreatic β-cell. To investigate this further, INS-1 cells were
treated with 1 and 2mM of AICAR for 24 h. Results showed
that AICAR decreased IκBα protein levels in a dose-
dependent manner, suggesting that AMPK activation leads
to reduced tethering of NF-κB in the cytosol (Figures 6l andm).
AMPK activation alters β-cell calcium homeostasis and
SERCA2 activity. To explore the functional effects of
proinflammatory signaling on β-cell Ca2+ homeostasis, the
FLIPR Calcium 6 Assay Kit (Molecular Devices, Sunnyvale,
CA, USA) was used to measure basal cytosolic Ca2+ levels
and Ca2+ mobilization from the ER in response to the
indicated compounds (Figures 7a–d). Experiments were
performed both in the presence (Figures 7a and b) and
absence of extracellular Ca2+ (Figures 7c and d) and showed
that IL-1β, SNAP and AICAR significantly increased basal
cytosolic Ca2+ levels and decreased ER Ca2+ levels (as
assessed by changes in the ΔF/F0 ratio following caffeine
treatment). Notably, the effects of IL-1β were reversed
by cotreatment with L-NMMA. In aggregate, these results
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Figure 4 SERCA2 protein stability is decreased by NO-dependent signaling and AMPK activation. INS-1 cells were treated with dimethyl sulfoxide (DMSO) (CT) or 10μM
CHX combined with or without 300 mM of SNAP (SN) or 2 mM AICAR (AC) for 24 h. Total protein was isolated; immunoblot was performed using antibodies against SERCA2 and
actin (a and b). (c) Quantitative protein levels of SERCA2 are shown graphically. Indicated comparisons are significantly different (**Po0.01)
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demonstrate that proinflammatory NO-mediated signaling as
well as AMPK activation alter β-cell Ca2+ compartmentaliza-
tion, resulting in decreased ER Ca2+ levels and a reciprocal
increase in basal cytosolic Ca2+.
Next, INS-1 cells were incubated with the Ca2+ dye
fura-2/AM. Basal Ca2+ levels within the cytosolic compartment
and changes in Ca2+ transit following ER Ca2+ depletion with
caffeine were analyzed according to the schematic indicated
in Figure 7e. To provide an additional estimate of SERCA
pump activity, the slope of the change in the fura-2/AM ratio
following withdrawal of caffeine and closure of RyR was
calculated using linear regression (Figure 7e). INS-1 cells
were then treated with AICAR for 0, 3 and 16 h.Whereas 3 h of
AICAR treatment did not alter the ΔF/F0 ratio (Figure 7g),
AICAR treatment for 16 h significantly reduced theΔF/F0 ratio.
Interestingly, both short-term (3 h) and long-term (16 h) AICAR
led to decreased Ca2+ reuptake following removal of caffeine.
Taken together, these results were consistent with observed
changes in SERCA2b expression and suggest that AMPK
activation impairs SERCA activity (Figure 7d), whereas
chronic AMPK treatment leads to a reduction in ER calcium
storage.
Inhibition of iNOS and AMPK protect INS-1 cells from
IL-1β-induced apoptosis. Finally, to determine whether the
observed rescue of SERCA2 expression also influenced cell
survival, INS-1 cells were treated with L-NMMA, C-PTIO or
CC alone or combined with IL-1β, and the ratio of cleaved
caspase-3 to total caspase-3 expression was measured by
immunoblot. Cleaved caspase-3 expression was significantly
increased with IL-1β treatment, but reduced to control levels
in the presence of L-NMMA, C-PTIO and CC (Figures 8a and b).
Next, the CellTiter-Glo Luminescent Cell Viability Assay
(Promega, Madison, WI, USA) was used in INS-1 cells
treated with the same combination of compounds above as
well as SNAP and AICAR alone. Viability was similarly
reduced with IL-1β, SNAP and AICAR, whereas L-NMMA,
C-PTIO and CC were able to rescue IL-1β-mediated cell
death (Figure 8c), indicating that loss of β-cell survival under
proinflammatory conditions occurs through NO- and AMPK-
dependent pathways and is closely correlated with changes
in SERCA2b expression and activity.
Discussion
We and others have demonstrated diminished β-cell SER-
CA2b levels in human and rodent models of type 1 and type 2
diabetes,1,20,21 with alterations in SERCA2b expression
leading to impaired Ca2+ homeostasis and insulin secretion,
activation of ER stress signaling pathways and altered
β-cell survival.3,5,7,8 Ilham and co-workers22 previously
descrbed a role for proinflammatory cytokines and induction
of the NF-κB-dependent gene, iNOS, in the loss of β-cell
SERCA2b mRNA and protein expression. However, whether
NO-mediated changes in SERCA2b expression and/or
activity are primarily due to a transcriptional or post-
translational mechanism remains unexplored. Moreover, the
downstream pathways that synergize with NO to alter
endoplasmic reticulum Ca2+ in the β-cell have not been fully
defined.
To address this, we first established the half-life of
SERCA2 protein andmRNA under basal and proinflammatory
conditions. Data from both INS-1 cells and rat islets
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demonstrate that treatment with the single cytokine IL-1β led
to decreased SERCA2 protein stability without significantly
altering mRNA half-life. Interestingly, treatment with the iNOS
inhibitor, L-NMMA, was capable of rescuing SERCA2 protein
under inflammatory conditions, but was unable to restore
mRNA levels, suggesting divergent regulation of mRNA and
protein expression under diabetic and inflammatory condi-
tions. Indeed, our previous work is consistent with this notion
and has shown that reductions in SERCA2b mRNA in models
of diabetes may arise instead from the loss of key
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Figure 7 IL-1β, SNAP and AICAR alter β-cell calcium homeostasis, and direct activation of AMPK impairs SERCA2 activity. To assess cytosolic Ca2+ levels, Calcium 6
fluorescence and fura-2/AM fluorescence ratios were measured as described under Materials and Methods. For Calcium 6 measurements (a–d), INS-1 cells were pretreated with
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transcriptional regulators such Pdx-1 and PPAR-γ, rather than
through decreased transcript stability.5,8
Although temporally regulated and controlled increases in NO
have important signaling effects in the pancreatic β-cell,23
chronically elevated NO generated under pathologic conditions
has a central role in cytokine-induced β-cell death through a
variety of effects, including decreased protein kinase B signaling,
potentiation of c-Jun N-terminal kinase (JNK) activation and
induction of irreversible DNA damage.24–26 However, a dominant
effect of NO is impaired mitochondrial oxidation and altered ATP
production, which occurs through inhibition of iron-sulfur
enzymes such as aconitase.27,28 These effects are quite potent
in the pancreatic islet, where treatment with IL-1β is associated
with at least a fourfold reduction in ATP levels.29
AMPK is a multisubstrate, heterotrimeric serine/threonine
kinase with a role in a variety of cellular pathways. AMPK is
activated directly through phosphorylation by one of three well-
described upstream kinases, LKB1, CaMKKor TAK1, whereas a
second major pathway of activation involves allosteric modula-
tion by AMP and ADP. Thus, AMPK activity increases in
response to any process that decreases ATP levels, including
NO-induced stress, hypoxia and glucose deprivation.30 Interest-
ingly, AMPK has also been shown to regulate ion transport as
well as cellular ATPase activity. In this regard, Alzamora et al.18
demonstrated direct phosphorylation of the kidney vacuolar H+-
ATPase byAMPK, and thismodification led to changes in cellular
localization and decreased activity of the protein pump. Similarly,
hypoxia in alveolar cells leads to AMPK-triggered inactivation
andendocytosis of the basolateral Na+,K+-ATPase,with resulting
impairments in lung fluid clearance.16
With these relationships in mind, we investigated a novel
link between SERCA2b and AMPK signaling, hypothesizing
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Figure 8 Inhibition of iNOS and AMPK protect INS-1 cells from IL-1β-induced apoptosis. INS-1 cells were treated with dimethyl sulfoxide (DMSO) (CT) or 5 ng/ml IL-1β (IL)
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that restraint of SERCA activity may be one way that
AMPK alters β-cell energy expenditure under inflammatory
conditions. ATPases are energetically expensive to
maintain and SERCA pumps alone have been estimated to
consume upwards of 7–25% of cellular ATP under normal
conditions.10–12 In support of our hypothesis, a recent
interactome study involving large-scale affinity purification-
mass spectrometry of the AMPKα subunit was performed in
INS-1 β-cells and identified SERCA2 as a potential AMPKα
binding partner.19 Indeed, our results show that chronic AMPK
activation decreases SERCA2 protein expression in INS-1
cells, rat islets and human islets through a mechanism
involving a reduction in protein half-life. Moreover, pharmaco-
logic as well as genetic inhibition of AMPK was capable of
rescuing cytokine-induced loss of SERCA2 expression and
cytokine-induced cell death. We explored a functional effect of
this relationship using intracellular Ca2+ imaging and demon-
strate that both short- and long-term AMPK activation alters
SERCA activity levels, leading to reductions in ER Ca2+ with a
reciprocal increase in cytosolic Ca2+.
Although beneficial metabolic effects of AMPK have been
well described in peripheral tissues including the liver and
skeletal muscle,30 the effects of AMPK activation in the β-cell
remain somewhat controversial. Divergent effects of AMPK
appear to be dependent on both the level of activation as well
as the chronicity of activation in experimental models. In the
short-term, AMPK stimulates insulin secretion and may
promote recovery from stress.31 In contrast, chronic or long-
term activation, similar to the paradigm applied in our study,
has been linked to impairments in insulin secretion as well as
altered β-cell survival.31–33 Indeed, a proapoptotic role for
AMPK has been described in other cell types and is linkedwith
a variety of mechanisms including cell cycle arrest, activation
of p53 and JNK signaling.34 Specifically in the β-cell and
consistent with our findings, previous studies suggest that
pharmacologic activation of AMPK with AICAR or virally
induced constitutive activation of AMPK resulted in islet and
β-cell death, whereas a dominant-negative form of AMPK
(AMPK-DN) was capable of protecting against cytokine-
induced apoptosis.14,35 Similarly, constitutive activation of
AMPK within transplanted islets decreased insulin secretion
and β-cell survival in STZ-treated diabetic mice.36
Our study raises a number of interesting questions for future
investigation. Although we suggest an initiating role for ATP
depletion in our model, there are likely other pathways that
lead to AMPK activation under inflammatory conditions. In
fact, a study by Gordon et al.33 showed that NO modulates
AMPK activity in the β-cell through an IRE-1-dependent
mechanism as part of the unfolded protein response.33 It is
also tempting to speculate that increased cytosolic Ca2+
resulting from initial pertubations in SERCA activity may
augment AMPK activation through a CaMKK-dependent
pathway, although this remains to be tested. Similarly, an
interesting relationship uncovered by our data is that
pharmacologic inhibition of AMPK with CC and treatment with
the AMPK-DN construct attenuated IL-1β-induced iNOS gene
and protein expression. This result was further confirmed by
measuring nitrite concentrations in the culture media. Similar
to our results, Santos and co-workers31,37 have shown that
knockdown of AMPK in MIN-6 β-cells blocked cytokine- or
lipopolysaccharide-induced expression of iNOS. These data
and ours suggest that AMPK is not only activated by NO
signaling but may also be responsible for amplifying the
inflammatory response. AICAR has previously been shown to
activate NF-κB in a neuroblastoma cell line through degrada-
tion of IκBα.34 We investigated this possibility in INS-1
cells, and similarly found that AICAR treatment led to a
dose-dependent reduction in IκBα expression in the pancrea-
tic β-cell.
In aggregate, these data provide evidence for a novel
pathway that links NO and AMPK signaling with altered β-cell
calcium homeostasis and provide additional insight into the
regulation of β-cell survival under inflammatory conditions that
typify both type 1 and type 2 diabetes.
Materials and Methods
Materials. CHX, actinomycin D and CC were purchased from Sigma-Aldrich
(St Louis, MO, USA), whereas AICAR was from Toronto Research Chemicals
(Toronto, ON, Canada). Recombinant mouse and human IL-1β, TNF-α and
interferon-γ (IFN-γ) were purchased from Life Technology (Carlsbad, CA, USA),
whereas caffeine and L-NMMA were from Santa Cruz Biotechnology (Santa Cruz,
CA, USA). C-PTIO and SNAP were obtained from Cayman Chemical (Ann Arbor,
MI, USA).
Animals, islet isolation and human islets preparation. Male wistar
rats (250–300 g) were purchased from Harlan Lab (Indianapolis, IN, USA), and
maintained under protocols approved by the Indiana University Institutional Animal
Care and Use Committee, the US Department of Agriculture’s Animal Welfare Act
(9 CFR Parts 1, 2 and 3) and the Guide for the Care and Use of Laboratory
Animals.38 Rat pancreatic islets were isolated by collagenase digestion as
described previously,39 hand-picked and allowed to recover overnight in RPMI-1640
medium supplemented with 10% fetal bovine serum, 100 U/ml penicillin and 100 μg/ml
streptomycin. Human cadaveric islets isolated from non-diabetic donors were obtained
from the Integrated Islet Distribution Program or the National Disease Research
Interchange. Upon receipt, human islets were hand-picked and allowed to recover
overnight in DMEM medium containing 5.5 mM glucose, 10% fetal bovine serum,
100 U/ml penicillin and 100 μg/ml streptomycin.
Cell culture and in vitro islet treatment. INS-1 832/13 rat insulinoma
cells were cultured as described previously.7 An AMPK-DN recombinant adenovirus
expressing an HA-tagged human α1-subunit with a D159A mutation in the ATP-
binding domain was purchased from Eton Biosciences (San Diego, CA, USA). An
adenovirus encoding firefly luciferase under the control of the cytomegalovirus
promoter was used as a control. For loss of function studies, INS-1 832/13 cells
were transduced with 107 PFU/ml of control or AMPK-DN adenovirus when cells
reached 60–70% confluency. Rat, mouse or human islets were transduced on the
day of isolation or receipt using 5 × 107 PFU/ml of control or AMPK-DN adenovirus.
After overnight incubation, the culture media was replaced with fresh media followed
by an additional 24–32 h of culture. To simulate the inflammatory milieu of diabetes,
cells and rat islets were treated in RPMI media containing 5 ng/ml of mouse IL-1β
for indicated times. For human islet studies, DMEM media containing 5 ng/ml of
mouse or human IL-1β, 10 ng/ml TNF-α and 100 ng/ml IFN-γ was used. Time-
course experiments were performed to determine the half-life of SERCA2b protein
or mRNA using 10 μM CHX or 1 μg/ml actinomycin D, respectively. The CellTiter-
Glo Luminescent Cell Viability Assay Kit was used according to the manufacturer’s
instructions. NO generation was measured using the Promega Griess Reagent
System (Madison, WI, USA).
Quantitative real-time PCR and immunoblot analysis. Cultured
INS-1 832/13 cells or isolated rat islets and human islets were washed with PBS
and quantitative RT-PCR was performed using previously published methods and
primer sequences.5 Immunoblot analysis was performed as described previously
using the following primary antibodies: anti-SERCA2 goat antibody (1:1000;
Santa Cruz Biotechnology); anti-phospho-AMPKα Th172 rabbit antibody
(1 : 1000; Cell Signaling, Beverly, MA, USA); anti-total AMPKα rabbit
antibody (1 : 1000; Cell Signaling); anti-total acetyl-CoA carboxylase (ACC)
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antibody (1 : 1000; Cell Signaling); anti-phospho-ACC (1:1000; Cell Signaling);
anti-total caspase-3 rabbit antibody, which detected both cleaved and total
caspase-3 (1 : 1000; Cell Signaling); anti-iNOS rabbit antibody (1 : 1000; Millipore,
Billerica, MA, USA); and anti-actin mouse antibody (1 : 10 000; MP Biomedicals,
Santa Ana, CA, USA).
Cytoplasmic calcium (Ca2+) imaging. Intracellular cytosolic Ca2+ was
measured using the FLIPR Calcium 6 Assay Kit (Molecular Devices) according to
the manufacturer’s instructions. In brief, INS-1 832/13 cells were plated at a density
of 5000 cells per well in black wall/clear bottom 96-multiwell plates from Costar
(Tewksbury, MA, USA) and cultured for 2 days before treatment. After ~ 22 h of
treatment, Calcium 6 reagent was added directly to cells, and cells were incubated
for an additional 2 h at 37 °C and 5% CO2. Data acquisition on the FlexStation 3
system (Molecular Devices) was performed at room temperature using a 1.52- s
reading interval throughout the experiments. To empty ER Ca2+ stores, caffeine
dissolved in Hank’s balanced salt solution (HBSS) was injected into each well to
achieve a final concentration of 10 mM, and fluorescence was recorded for an
additional 120 s. To image under Ca2+ free conditions, following 2 h of incubation
with the Calcium 6 reagent, media were substituted with HBSS without Ca2+ before
data acquisition.
To provide an additional measure of intracellular Ca2+ mobilization, the ratiometric
calcium indicator fura-2/AM from Life Technologies as described previously40 was
applied. In brief, INS-1 832/13 cells were seeded in glass bottom 50 mm plates for
48 h and then treated as indicated. Before imaging, INS-1 cells were incubated at
37 °C and 5% CO2 in 4 μM fura-2/AM and 0.02% pluronic F127 (Life Technologies)
for 1 h, and then washed and incubated with HBSS (Life Technologies) supplemented
with 0.1% BSA and 2.5 mM CaCl2. A small-volume chamber from Warner
Instruments (Hamden, CT, USA) was mounted on the microscope stage; INS-1
cells were perfused with a gradient pump (Bio-Rad, Hercules, CA, USA) and
maintained at 37 °C and 5% CO2. To activate ryanodine receptors and reversibly
empty ER Ca2+ stores, 10 mM caffeine in basal HBSS was used for 2 min. Fura-2/AM
fluorescence was measured with excitation at 340 and 380 nm and emission at
510 nm, and images were captured using a Zeiss Z1 microscope (Carl Zeiss
Microscopy, Oberkochen, Germany) with a x10 objective. Results were analyzed with
Zen Blue software (Zeiss, Oberkochen, Germany). For both Calcium 6 and fura-2/AM
experiments, basal Ca2+ (F0) measurements and Max-Min Ca2+ measurements (ΔF)
were assessed as described previously.8
Statistical analysis. Results are displayed as the means±S.E.M., and at
least three sets of replicates were performed for each experiment. GraphPad Prism
statistics software (GraphPad Software, La Jolla, CA, USA) was used to draw one-
phase decay curves for protein and mRNA half-life determination and for linear
regression of the Ca2+ reuptake response following caffeine withdrawal. Differences
between groups were examined for significance using either a two-tailed Student's
t-test or one-way ANOVA followed by the Tukey–Kramer posttest. A P-valueo0.05
was taken to indicate the presence of a significant difference between groups.
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